SAB Biotherapeutics prices $85 million public offering at $3.85 per share Mar 17, 2026 10:46PM
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants Mar 17, 2026 10:46PM
SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company Oct 25, 2021 07:39AM